| Medical and Health Sciences | 2021-2025 | 41 | US 21 | 99.99 |
| Economics and Finance | 2021-2025 | 881 | US 258 | 96.41 |
| Epidemiology | Lifetime | 168 | US 90 | 99.79 |
| Hepatology | Lifetime | 45 | US 20 | 99.71 |
| Oncology | Lifetime | 862 | US 475 | 98.13 |
| Gastroenterology | Lifetime | 746 | US 284 | 34.68 |
| Epidemiology | 2021-2025 | 9 | US 4 | 99.95 |
| Hepatology | 2021-2025 | 2 | US 1 | 99.95 |
| Oncology | 2021-2025 | 123 | US 53 | 99.21 |
| Surgery | 2021-2025 | 456 | US 177 | 96.40 |
| Econometrics and Quantitative Economics | 2021-2025 | 608 | US 146 | 96.42 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 607 | US 210 | 92.90 |
| Cancer Research | 2021-2025 | 207 | US 74 | 88.83 |
| Pathology and Forensic Medicine | 2021-2025 | 325 | US 108 | 89.05 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 29 | US 15 | 99.82 |
| Liver Disease Diagnosis and Treatment | Lifetime | 107 | US 42 | 99.81 |
| Liver Disease and Transplantation | Lifetime | 66 | US 27 | 99.73 |
| Hepatitis C virus research | Lifetime | 180 | US 60 | 99.43 |
| Hepatitis B Virus Studies | Lifetime | 282 | US 102 | 99.17 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 463 | US 221 | 98.83 |
| Colorectal Cancer Screening and Detection | Lifetime | 269 | US 123 | 98.86 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 310 | US 103 | 98.62 |
| Cancer, Lipids, and Metabolism | Lifetime | 397 | US 204 | 98.43 |
| Gastric Cancer Management and Outcomes | Lifetime | 863 | US 260 | 98.36 |
| Economic and Financial Impacts of Cancer | Lifetime | 239 | US 158 | 97.19 |
| Diverticular Disease and Complications | Lifetime | 825 | US 316 | 94.07 |
| Multiple and Secondary Primary Cancers | Lifetime | 896 | US 384 | 92.06 |
| Cancer Mechanisms and Therapy | Lifetime | 978 | US 370 | 91.71 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 2 | US 1 | 99.96 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 10 | US 6 | 99.94 |
| Liver Disease and Transplantation | 2021-2025 | 8 | US 4 | 99.82 |
| Hepatitis C virus research | 2021-2025 | 12 | US 4 | 99.65 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 48 | US 17 | 99.30 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 23 | US 7 | 99.37 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 33 | US 21 | 98.29 |
| Hepatitis B Virus Studies | 2021-2025 | 52 | US 8 | 98.60 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 71 | US 21 | 98.16 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 93 | US 33 | 97.90 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 37 | US 19 | 95.03 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 331 | US 72 | 97.19 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 555 | US 109 | 96.31 |
| COVID-19 and healthcare impacts | 2021-2025 | 568 | US 187 | 92.31 |
| Alcohol Consumption and Health Effects | 2021-2025 | 195 | US 75 | 92.25 |
| Global Cancer Incidence and Screening | 2021-2025 | 579 | US 244 | 91.68 |
| Genetic factors in colorectal cancer | 2021-2025 | 883 | US 285 | 86.97 |
| Liver physiology and pathology | 2021-2025 | 360 | US 56 | 80.51 |
| Cancer Mechanisms and Therapy | 2021-2025 | 614 | US 80 | 77.68 |
